Quick Heal Technologies Ltd. I

Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Vi man Nagar, Pune 411014. India.

Ref. No.: QHTL/Sec/SE/2025-26/25 August 7, 2025

The Manager, The Manager, Corporate Services, Corporate Services, Mumbai – 400 001 Bandra (E), Mumbai – 400 051 Ref: Security ID: QUICKHEAL Symbol: QUICKHEAL Security Code: 539678 Series: EQ

BSE Limited, National Stock Exchange of India Limited, 14th floor, P J Towers, Dalal Street, Exchange Plaza, Bandra Kurla Complex,

Subject: Outcome of Board Meeting August 07, 2025.

Dear Sir / Madam,

We wish to inform you that the Board of Directors at its meeting held on August 7, 2025 through video conferencing which commenced at 05:30 PM IST and concluded at 7:00 PM, has approved following:

• 1. Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended June 30, 2025.
• 1. Appointment of Ms. Amita Mirajkar as an Additional Director in the category of Woman Independent Director, subject to approval of the shareholders in ensuing Annual General Meeting. Details of the said Appointment are enclosed in Annexure A.
• 1. Appointment of Internal Auditor for the Financial Year 2025-26. Details of the said Appointment are enclosed in Annexure B.
• 1. Pursuant to Regulation 33 of SEBI Regulations, we have enclosed herewith Limited Review Report for the unaudited Standalone & Consolidated financial results for the quarter ended June 30, 2025 from our Statutory Auditors M/s MSKA & Associates, Chartered Accountants.

We also enclose herewith copy of the Press Release being issued in respect of aforesaid financial results and presentation on financial results.

This is for your information and records.

For Quick Heal Technologies Limited

Vikram Dhanani Compliance Officer Vikram Bharat Dhanani Digitally signed by Vikram Bharat Dhanani Date: 2025.08.07 21:08:44 +05'30'

Quick Heal Technologies Ltd. I

Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Viman Nagar, Pune411014. India.

ANNEXURE A

Sr. No.	Details of Event that	Information of such events
	needs to be provided
1	Name of the Director	Amita Mirajkar
2	Reason for Change –	Appointment as an additional, non – Executive, Independent
	Appointment	Director.
3	Date of Appointment	August 07, 2025
4	Brief Profile	Ms. Amita Mirajkar has done MBA in Technology Management from
		University of Phoenix in 2013 and BE in Computer Engineering from
		Maharashtra Institute of Technology in 2003
		Ms. Amita is Vice President at EXL Services and before that she was
		Co – Founder & CEO of Clairvoyant India.
		She has Achieved various Recognition and Awards including: -
		1. Women in Tech Awards 2024 Finalist by Nasscom.
		2. Innovative Data Engineering Project of the year, 2024.
		3. ETRise top MSMEs Winner.
		Ms. Amita has a combination of deep technology expertise, proven
		leadership capabilities and a strong governance foundation.
		Ms. Amita has comprehensive qualifications to address all key
		requirements for Independent Director.
5	Disclosure of	NA
	relationships between
	directors

Quick Heal Technologies Ltd. I

Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Viman Nagar, Pune411014. India.

ANNEXURE B

Sr. No.	Details of Event that needs to be provided	Information of such events
1	Name of the Internal Auditor	P G BHAGWAT LLP
2	Reason for Change – Appointment	Appointment as an Internal Auditor
3	Date of Appointment	August 07, 2025
4	Brief Profile	P G BHAGWAT LLP is a Chartered Accountancy Firm that's been in the profession for over 85 years, providing a wide range of services such as audit and assurance, direct and indirect tax consultancy, management and accounting consultancy, and other financial services. By maintaining integrity, transparency, objectivity and independence, its team of dedicated and experienced professionals provide high-quality services to its clients. The firm possessed skills in effectively managing various assignments viz. Internal Audit, Accounts and Finance. The firm is competent in conducting Internal Audit by implementation of effective Risk & Governance framework with focus on controls assessment and leveraging technology.
5	Disclosure of relationships between directors	NA

QUICK HEAL TECHNOLOGIES LIMITED

Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune - 411014

CIN: L72200MH1995PLC091408 STATEMENT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED AND ITS SUBSIDIARIES FOR THE QUARTER ENDED JUNE 30, 2025 ~ in Crores, except earnings per share) Quarter ended Year ended Sr. No. Particulars June 30, 2025 March 31, 2025 June 30, 2024 March 31, 2025 Unaudited (refer note 1) Unaudited (Audited) I Income Revenue from operations 57.23 65.14 70.29 279.53 Other income 5.75 5.60 5.06 20.77 Total income 62.98 70.74 75.35 300.30 2 Expenses Cost of material consumed 0.86 I.OJ 1.37 6.10 Purchase of security software products - . - 0.45 Changes in inventory of security software products (0.06) 0.61 . 0.58 Employee benefits expense 43.89 48.72 44.31 185.55 Finance costs 0.06 0.06 0.05 0.22 Depreciation and amortisation expense 2.96 3.63 2.79 12.96 Other expenses 22.27 23.28 22.02 93.44 Total expenses 69.98 77.31 70.54 299.30 3 Profit/(loss) before tax (1-2) (7.00) (6.57) 4.81 1.00 4 Tax expense Current tax . (1.66) 1.03 . Adjustments of tax relating to earlier periods (Net) . . . 0.44 Deferred tax (benefit) (1.49) (l.66) (0.25) (4.48) Total tax expense/ (benefit) (1.49) (3.32) 0.78 (4.04) 5 Profit/ (loss) after tax (3-4) (5.51) (3.25) 4.03 5.04 6 Other comprehensive income/(loss) (net of tax) Items that will not be reclassified subsequently to profit or loss : Gain/ (loss) on re-measurement of defined benefit plans 0.22 (0.06) 0.21 (0.19) Net (loss) or gain on FVOCI instruments - (0.17) . (0.17) Items that will be reclassified subsequently to profit or loss : Exchange differences on translation of foreign operations 0.09 . 0.03 0.07 Total other comprehensive income/ (loss) for the period 0.31 (0.23) 0.24 (0.29) 7 Total comprehensive income/(loss) (after tax) (5+6) (5.20) (3.48) 4.27 4.75 8 Paid-up equity share capital (face value oft JO each, fully paid up) 54.02 54.00 53.54 54.00 - 9 Other equity excluding revaluation reserves as per balance sheet /,.._:(F ~echnc ~uVo,Q, i., . . . 387.48 10 Earnings/ (loss) per share of~ 10 each: (not annualised except for the year ended March) 1 ~ - Pun e cl a) Basic

~

b) Diluted -~ ,.,.~) (1.00) (0.60) 0.74 0.91 ~*2 *Y --

-t, ~ (1.00) (0,60) 0.75 0.94

QUICK HEAL TECHNOLOGIES LIMITED

Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune - 411014 CIN: L72200MH199SPLC091408

NOTES TO THE STATEMENT OF CONSOLIDATED UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED AND ITS SUBSIDIARIES FOR THE QUARTER ENDED JUNE 30, 2025

Notes to financial results:

• I Thi: unaudited consolidated financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under Sec11..1 on 133 or the Companies Act, 2013 read with the Companies (Indian Accounting Standard Rules), 2015 (as amended) and in terms of Rcgu.lQnon 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 The above financial results for the quarter ended June 30, 2025 have been subjected to limited review by the statutory auditors of the Holding Company and reviewed by the Audit Comminee ;3nd approved by the Board of Directors of the Holding Company at the meeting held on August 7, 2025 Figures for the quarter ended March J l, 2025 arc the balancing figures between the audited figures m respect of the full years and published year to date figures of nine months ,:nrle,1 n~cemher 11 2024
• ? Ouriog the year ended March J I, 2025, the Regional P,F Commissioner ("RPFC") passed an order under Section 7A & 7Q of the Employees' Provident Funds and Miscellaneous Provisions Act. I 952 ("Act") demanding"' 5 01 (including interest of"' 2.49) on the grounds that ,t r.ilod 10 remit Provident Fund ("PF") on wages for its employees for the period from September 2014 to March 2019 for certain allowances of salary The Holding Company filed an appeal before the Central Government Industrial Tribunal Cum-Labour Court ("CGJT") challenging the C:mployctS' Provident Fund Organisation's ("EPFO") order along with the application under Section 70 of the Act seeking a waiver from pre-deposit of the alleged Provident Fund Contributions till the final disposal of the Appeal The CGIT, after hearing the submissions made, passed ::.n Order and directed RPFC, not to proceed with the recovery against the Holding Company on depositing 30% of the total amount assessed,

Tha Holding Company, based on the legal counsel's opinion, is of the view that the claim made by the RPFC is not probable, and accordingly no provision is recorded in the financial results of the quarter ended June 30, 2025

J O umge5 in Key Managerial Personnel and Director of the Holding Company:

i Mr Vishal Salvi resigned on June 26, 2025 as Chief Executive Officer which was accepted by Board of Directors on July 9, 2025 He would vacate his office w,e f August 31 , 2025

u Ms Arnita Mirajkar is appointed as an Additional Director of Holding Company we f August 7. 2025 subject to approval of the shareholders at the ensuing Annual General Meeting of the Holding Company

4 The Group is engaged 1n providing cyber security software solutions The Chief Operating Decision Maker (CODM) reviews the information pertaining to revenue of each of the target customer group (segments) vi.z. consumer, enterprise and government However, based on similarity oractnnucsfproducts, risk and reward structure, organisation structure and internal reporting systems, the Group has structured its operations into one operating segment viz cyber security platform and as such there is no separate reportable operating segment as defined by Ind AS 108 ··operating segments"

// '\'Ov " 'V/0~ For and on behalf of the Board of Directors (l·-a .,,.. ti16~Katkar

~ o -a"-#J · DIN No: 00397191

o ro

... - . o· ...... ,.__ ,:;. -.-,-

• Previous period's figures have been regrouped / reclassified wherever necessary to make them comparable with the current period's classification / disclosure - ..,.,- _.., - ....................

I; Pune f I Place Pune Chairman & Mana,:in,: Director Date: August 7, 2025

QUICK HEAL TECHNOLOGIES LIMITED Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune - 411014 CIN: L72200M111995PLC091408

STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED FOR THE QUARTER ENDED JUNE 30, 2025 (fin Crores, except earnings per share) Quarter ended Year ended Sr. No. Particulars June 30, 2025 March 31, 2025 June 30, 2024 March 31, 2025 (Unaudited) (refer note 1) (Unaudited) (Audited) I Income Revenue from operations 57.23 65.13 70.29 279.53 Other income 5.75 5.54 5.06 20.72 Total income 62.98 70.67 75.35 300.25 2 Expenses Cost of material consumed 0.83 1.03 1.36 6.11 Purchase of security software products . . . 0.45 Changes in inventory of security software products (0.06) 0.61 . 0.58 Employee benefits expense 43.82 48.55 44.17 184.95 Finance costs 0.06 0.06 0.05 0.22 Depreciation and amortisation expense 2.96 3.63 2.79 12.96 Other expenses 22.31 22.79 22.14 93.45 Total expenses 69.92 76.67 70.51 298.72 3 Profit/(loss) before tax (1-2) (6.94) (6.00) 4.84 1.53 4 Tax expense Current tax - (1.66) 1.03 . Adjustments of tax relating to earlier periods (Net) . . . 0.44 Deferred tax (benefit) (1.49) (1.66) (0.25) (4.48) Total tax expense/ (benefit) (1.49) (3.32) 0.78 (4.04) 5 Profit/ (loss) after tax (3-4) (5.45) (2.68) 4.06 5.57 6 Other comprehensive income/(loss) (net of tax) Items that will not be reclassified subsequently to profit or loss : Re-measurement of defined benefit plans 0.22 (0.06) 0.21 (0.19) Net (loss) or gain on FVOCl instruments . (0.17) . (0.17) Total other comprehensive income/(loss) for the period 0.22 (0.23) 0.21 (0.36) 7 Total comprehensive income/ (loss) (after tax) (5+6) (5.23) (2.91) 4.27 5.21 ⁸Paid-up equity share capital (face value oft 10 each, fully paid up) - 54.02 54.00 53.54 54.00 9 Other equity excluding revaluation reserves as per balance sheet -<_echn ~ - . . 387.84 l{EPun 10 Earnings/ (loss) per share off to each: '\ ~ (not annualised except for the year ended March) }ll a) Basic ~ .-;:-., (0.99) (0.50) 0.76 1.04 b) Diluted * ^{2 11~} c. (0.99) (0.50) 0.74 1.01 --

QUICK HEAL TECHNOLOGIES LIMITED

Regd. Office: Solitaire Business Hub, Office No. 7010 C & D, 7th Floor, Opposite Neco Garden Society, Viman Nagar, Pune - 411014 CIN: L72200MH1995PLC091408

NOTES TO THE STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS OF QUICK HEAL TECHNOLOGIES LIMITED FOR THE QUARTER ENDED JUNE 30, 2025

:\oles to financial results:

I	The unaudited standalone financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) notified under Section 133 of the Companies Act, 2013 read with the Companies (Indian Accounting Standard Rules), 2015
	(as amended) and in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015. The above financial results for the quarter ended June 30, 2025 have been subjected to limited review by the slBtutory
	audhors of the Company and reviewed by the Audit Committee and approved by the Board of Directors of the Company at the meeting held on August 7, 2025. Figures for the quarter ended March 31 , 2025 are the balancing figures between the
	audited figures m respect of the full years and published year to date figures of nine months ended December 31, 2024,

• 2 During the year ended March 31, 2025, the Regional P.F. Commissioner ("RPFC") passed an order under Section 7 A & 7Q of the Employees' Provident Funds and Miscellaneous Provisions Act, 1952 (" Act") demanding f 5.01 (including interest off 2 49) on the grounds that 11 failed to remit Provident Fund ("PF") on wages for its employees for the period from September 2014 to March 2019 for cenain allowances of salary. The Company filed an appeal before the' Central Govemmcnl Industrial Tribunal Cum-Labour Court ("CGIT") challenging the Employees' Provident Fund Organisation's ("EPFO") order along with the application under Section 70 of the Act seeking a waiver from pre-deposit of the alleged Provident Fund Contributions till the final disposal of the Appeal The CGIT, after hearing the submissions made, passed an Order and directed RPFC, not to proceed with the recovery against the Company on depositing 30% of the total amount assessed. The Company, based on the legal counsel's opinion, is of the view that the claim made by the RPFC is not probable, and accordingly no provision is recorded in the financial results of the quarter ended June 30, 2025.
• 3 Changes in Key Managerial Personnel and Director of the Company:

i Mr Vishal Salvi resigned on June 26, 2025 as Chief Executive Officer which was accepted by Board of Directors on July 9, 2025. He would vacate his office w.e.f August 31, 2025. ii Ms Arnita Mirajkar is appointed as an Additional Director of Company w,e_f August 7, 2025 subject to approval of the shareholders at the ensuing Annual General Meeting of the Company.

• 4 The Company is engaged in providing cyber security software solutions The Chief Operating Decision Maker (CODM) reviews the information pertaining to revenue of each of the target customer group (segments) viz. consumer, enterprise and government However, based on similarity of activities/products, risk and reward structure, organisation strucrure and internal reporting systems, the Company has strucrured its operations into one operating segment viz. cyber security platform and as such there is no separate reportable operating segment as defined by Ind AS I 08 "Operating segments".
• 5 Previous period's ogures have been regrouped/ reclassified wherever necessary to make them comparable with the current period's classification I disclosure.

Place; Pune Date: Au1,'1JSl 7. 2025

For and on behalf of the Board of Directors

Kailash Katkar Chairman & Managing Dirtttor DIN No: 00397191

Quick Heal Technologies Limited Reports Q1 FY26 Results

7 th , August 2025: Quick Heal Technologies Limited, a global provider of cybersecurity solutions, today announced its audited financial results for the quarter ended on June 30, 2025.

Particulars (₹ Cr)	Q1 FY25	Q4 FY25	Q1 FY26
Revenue	70.3	65.1	57.2
EBITDA	2.6	(8.5)	(9.7)
EBITDA Margin	3.7%	-13.0%	-17.0%
PAT	4.0	(3.3)	(5.5)
PAT Margin	5.7%	-5.0%	-9.6%

Key Financial Highlights:

Vishal Salvi, Chief Executive Officer, Quick Heal Technologies Limited, commented, "Q1 FY26 was softer than anticipated, primarily impacted by headwinds in the consumer business, deferral of key enterprise deal closures. While these factors affected near-term performance, we have strengthened our partner ecosystem, and accelerated adoption of our next-gen cybersecurity solutions. During the quarter, we made meaningful strategic progress launching new offerings, expanding our brand footprint, forging government partnerships, and advancing international growth. These efforts, alongside our continued investments in differentiated, AI-led innovations, position us to drive more predictable and sustainable growth in the quarters ahead."

Ankit Maheshwari, Chief Financial Officer, Quick Heal Technologies Limited, added, "The topline performance this quarter was milder than forecasted, we are aggressively working towards renewing our momentum in consumer business and deal closures in the Enterprise business. We continue to invest in R&D and more so in Sales & Marketing to build a large qualified pipeline and predictable growth for future quarters. These measures combined with disciplined expense management, position us to expand margins as we ramp up revenue. We are confident that this balanced approach will deliver improved operating leverage and sustainable shareholder value."

Key Highlights of Q1 FY26 include:

● AntiFraud.AI Freemium Launch: Introduced a freemium offering to accelerate adoption amongst the consumers.

• Partnership: Partnered with Bhashini, to embed multilingual AI in cybersecurity, driving digital inclusion and privacy compliance.
• Analyst Recognition: Seqrite Featured in a report by a leading global analyst firm.
• Partner & Customer Event: Hosted a successful engagement in Bengaluru, coupled with a targeted Data Privacy awareness campaign.
• 360-Degree Campaign in Tamil Nadu: Rolled out a comprehensive brand advocacy initiative via user-generated content, engaging over 100 micro-influencers.
• International Growth: Achieved approximately 2x year-over-year revenue growth in key international markets.
• Leadership Addition: Onboarded a new Vice President of Channel & Alliances to drive partner ecosystem expansion.

As Quick Heal Technologies Limited moves into Q2 FY26, the company remains focused on sharpening execution, deepening customer relationships, and harnessing AI innovations to simplify cybersecurity at scale. With strategic investments, strengthened partnerships, and disciplined financial management, Quick Heal Technologies Limited is well-positioned to deliver resilient, long-term growth and value for all stakeholders.

As a leading Indian cybersecurity vendor providing trusted indigenous cybersecurity solutions , Quick Heal is well positioned as India's alternative for Atmanirbharta in the domain to safeguard the nation's digital infrastructure and enhance cyber resilience amid escalating geopolitical conflicts and growing global cyber threats.

About Quick Heal Technologies Limited

Quick Heal Technologies Limited is a leading global cybersecurity solutions provider. Incorporated in 1995 with a registered office in Pune, it offers end-to-end cybersecurity solutions across B2C, B2B, and B2G segments. With its widely recognized brands 'Quick Heal' and 'Seqrite', the company provides AIpowered, patented technologies that protect endpoints, networks, data, mobility, and cloud environments. Committed to R&D and innovation, Quick Heal Technologies continues to simplify security by delivering best-in-class protection against advanced cyber-threats to millions of customers, enterprises, and government organizations worldwide.

Earnings Presentation Q1-FY26

7 th Aug 2025

Global Cybersecurity Trends

• Consolidation of security stack
• Investment & adoption of Generative AI in Cybersecurity
• Privacy driven Application & Data Decoupling
• Growing Adoption of Cloud Native Application
• Cybersecurity reskilling
• Organizations continue to accelerate their multiyear Security Service Edge (SSE) and Zero Trust (ZT) journey.
• Organizations continue to strengthen their security portfolio with new tools

India Cyber Threat Report: Key Highlights

Bigger spectrum of detections and endpoints

Over 369.01 million detections recorded across8.44 Million endpoints

detections Averaging 702 per minute

Behavioral-based detection

53.73 million

14.56% behavior-based detections, accounted for

of total detections

Significant increase from 12.5% in ²⁰²³

while 38% detections ~12 attacks per month per personal end user device

Primary attack vectors

68%

of attacks originated from Trojans and Infectors

Cloud detections contributed

were on-premise

India Cyber Threat Report: Key Highlights Contd…

91

Our Purpose

Innovate to "simplify" securing digital experience

Innovate Focus on grassroot research and adoption of new tech

Simplify Ease of manageability & operations for the end customers

Secure Getting the Job Done: Staying one step ahead of the threat actors to protect our customers

Our Journey so far

Protected early Generations of PCs 1993 -96

Secured PCs, Network & Emails 1996 -00

2001 -05

Ensured a safe digital experience for Individuals, Businesses and Government Organizations

2006 -10

Threat protection for Smart Phones and Tablets

2011 -16

Global Footprint, Foray into enterprise Segment with SEQRITE, & listed on BSE & NSE

2017 -19

Protecting Data, Transactions & Cloud transitions

2020 -23

Protecting Data, Transactions & Cloud transitions

2023 - 2 5

CSMA Product Stack Horizon -2 & 3 Product launches Experience Centre Leadership Strengthening India Cyber Threat Report Brand Refresh Anti Fraud Launch SIA Launch

This is us

Pioneer of cybersecurity in India Presence in 70+ countries 1st Listed Cybersecurity company in India Protecting 9 Million Active Devices ~1000 Cybersecurity Market Leader in India Patents Proud Partners Collaborators with US bodies NIST & AISIC ••• --- e

Professionals

Founded by the visionaries

Dr. Kailash Katkar Managing Director

A Visionary Founder and Leader, a Born Entrepreneur, and an Exemplary Trailblazer, he has transformed Quick Heal into a beacon of success and innovation in the Cybersecurity industry. His business acumen has consistently driven Remarkable financial performance, customer satisfaction, market leadership making Quick Heal & SEQRITE the preferred choice for customers globally.

Dr. Sanjay Katkar Joint Managing Director

Dr. Sanjay Katkar: Co-Founder of Quick Heal Technologies Limited, Joint Force, and Technology Powerhouse behind the company's journey. An unmatched Cybertech Mastermind, who is relentlessly shaping the company's global technology strategy and driving core research and development while pursuing product innovation to fortify cyber security.

Vishal Salvi Chief Executing Officer

A Prominent Global Leader, and Distinguished Cybersecurity Expert with a remarkable threedecade journey transforming the cybersecurity and information technology for global brands His recent role was Global Chief Information Security Officer and Business Head of the Cybersecurity Service Line at Infosys Ltd. He was previously associated with reputed organizations: HDFC Bank, Standard Chartered Bank & PWC.

Led by the Industry Experts

Ajit Zanjad VP & Head of Delivery

Ankit Maheshwari Chief Financial Officer

Anupama Katkar Chief of Operational Excellence

Ashish Pradhan Chief Technology Officer

Ashish Kadam Director, Government Business

Sangamesh S Head of Seqrite Labs

Deepak Mishra Head, Retail Sales

Sudhanshu Tripathi Chief Marketing Officer

Dr. Lalit Mohan Chief Product Officer

Samuel Sathayjith Senior VP, Enterprise Sales

Swapna Sangari VP, People & Culture

Our Strategy & Way Forward

Expanding Across 3 Levers

Geographic Reach

Setting up a strong foot in Indian Market Strategic Expansion in select focused geographies

Large Customers

Moving up the customer segments as the solutions mature Niche Solutions specifically targeted to Large Enterprises (SDP, SMAP, STI)

Product Stack:

Holistic cybersecurity stack for better protection and increased wallet share Increasing our coverage by launching new products

Seqrite Solution Stack

An approach to simplify cybersecurity by integrating security tools across a distributed enterprise

SIA: Seqrite Intelligent Assistant

Cybersecurity Market Landscape: Our Targeted Play

Expanding Serviceable Operatable Market

Source: Market Research & Company Estimates

Our Right to Win

• Largest Cybersecurity Lab in India with unique telemetry
• Holistic platformised cybersecurity solution
• Simple Integrated Architecture
• Solving unique value propositions & use cases (E.g.: On prem & cloud)
• Best in class support offerings
• Adoption of the new age tech in our stack
• Make in India
• Strong Partner Network across the country
• Proximity to the customers in India

Awards & Recognitions

Quick Heal is certified as one of the safest for browsing & banking by AVLab, Poland

Quick Heal is certified the "Product of the year" by AVLab, Poland

Seqrite Endpoint Protection for Best Performance by AV-Test

Seqrite Endpoint Protection Achieves AV-TEST Approved – Top Product Corporate Endpoint Protection

Strategic Collaborations

Thought Leadership & Brand Strengthening

• Seqrite launches"India Cyber Threat Report 2025" with DSCI -Threat Report launched by Shri S. Krishnan, Secretary, MeitY.

• Experience Centre

• Speaker sessions, sponsorships and presence in major cybersecurity events

• Brand Refresh
• ATL Campaigns
• ESG focused business

Thought Leadership Brand Building Awards & Recognition

• AV Test certifications
• Consortium Member of the US Artificial Intelligence Safety Institute
• Ranked 4.6/5 in Gartner Peer Insights.

Q1 FY26 - Business Highlights

Business Highlights

• Launched Anti Fraud Freemium ®
• Strong renewal momentum for large accounts on New Products ®
• Order Book: INR 24+ Cr as on date ®
• ~2X Growth in International Revenue YoY ®
• Deferred Revenue: INR 16.6 Cr as on 30th June 2025 ®
• Strategic account wins through Academy vertical ®

Deconstructing Current Business

Consumer Enterprise

■ ■

Enterprise Business Cloud & Non-Cloud

Cloud

Non-Cloud

Q1 FY26: Performance Highlights

₹ 57.2 Cr Net Revenue -18.6% YoY	₹ (9.7) Cr EBITDA -475.7% YoY	₹ (5.5) Cr PAT -236.7% YoY
₹ (1.0) Diluted EPS -235% YoY	₹ 31.7 Cr * Consumer Revenue -27.8% YoY	₹ 31.7 Cr * Enterprise Revenue -2.3%YoY

SECRITE I Quick Heal

*Based on gross revenues excluding deferred revenue, before adjusting for sales incentives

Market Leaders: Indian Consumer Antivirus Business

• 30 years into existence •
• Market leadership with over 30% in the Indian market •
• Robust Sales & Distribution network in India •

Our Approach:

• Launched AntiFraud.AI to tackle the financial frauds •
• Focus towards maintaining our market share in AV segment •
• Drive consumer awareness in the geography in cybersecurity specific domain •

Quick Heal

Consumer Marketing Campaigns

Moment Marketing

Focused Market Campaigns

Partner Connect with

Seqrite: Enterprise Arm of QH

Foray into Enterprise Segment with Seqrite Endpoint	• • •	Investments in EDR, XDR, Zero Trust & Data Privacy products Crossed 100 Cr in revenue Mid Market	• • •	DPDP product GTM International Expansion Key Academy Wins	93	89
Protection		Capture			27	32	32
FY16	FY17 – 22	FY23-24	FY25	FY26	FY 24	FY 25	FY26
	SMB Market Capture & Leadership	• Product. • • Book •	Horizon-3 Material New Product Revenue Projects & Order SIA Launch		• •	Q2-Q4 Enterprise Revenue Q1 Enterprise Revenue

120 121

Enterprise Marketing Campaigns

Launch of SIA (Seqrite Intelligent Assistant) GenAI Powered Virtual Security Analyst

Customer and Partner Event at Bangalore with TruVisor

Seqrite DPDP Lead Gen Campaign on LinkedIn Targeting DPOs

Seqrite XDR Webinar Targeting Midmarket Organizations with 150+ Attendees

CSR Update 4 States, 780 Volunteers 3 States, 120 Volunteers 3 States Earn & Learn - Direct Earn & Learn - InDirect Street Play

13,20,883 Lives Touched

1,34,006 People Reached

54,009 People Reached

Covered:

Maharashtra, Karnataka, Gujarat, West Bengal, Chhattisgarh, Uttar Pradesh, Assam, Punjab, Jammu & Kashmir, Madhya Pradesh

Consolidated P&L

PARTICULARS	Q1 FY25	Q4 FY25	Q1 FY26
Revenue	70.3	65.1	57.2
Direct Cost	1.6	1.8	0.9
Gross Profit	68.7	63.3	56.4
Gross Margin	97.7%	97.2%	98.5%
Operating Cost
Research and Development	34.5	33.6	31.3
Sales and Marketing	18.9	23.8	21.1
General Administration	12.7	14.4	13.6
Total Expenditure	66.1	71.8	66.1
EBITDA	2.6	(8.5)	(9.7)
EBITDA %	3.7%	-13.0%	-17.0%
Depreciation	2.8	3.6	3.0
EBIT	(0.2)	(12.1)	(12.7)
Other Income	5.1	5.6	5.8
Finance Cost	(0.1)	(0.1)	(0.1)
Profit Before Tax (PBT)	4.8	(6.6)	(7.0)
Tax	0.8	(3.3)	(1.5)
Profit After Tax (PAT)	4.0	(3.3)	(5.5)
PAT Margin	5.7%	-5.0%	-9.6%

All values are in INR Cr, unless otherwise stated

Capital Market Data

Shareholding Pattern (as on 30th June 2025)

Stock Market Performance (as on 30 th June 2025)

Sensex Quick Heal-BSE

Price Data (as of 30 th June 2025)
Face Value	10.00
Market Price	370.80
52 Week H/L	825.90/252.00
Market Cap (INR Mn)	20,032.63
Equity Shares Outstanding (Mn)	54.03
1 Year Avg. Trading Volume ('000)	354.62
1 Year Avg. Net Turnover (Mn)	181.71

Disclaimer

For further details, please feel free to contact our Investor Relations Representatives:

Mr. Anuj Sonpal Valorem Advisors Email: [email protected] Tel: +91-22-4903 9500 VJ\LOREM ADVISORS

Investor Relations Officer

Mr. Deepak Kumar [email protected]

Company Secretary

Mr. Sarang H Deshpande [email protected] +91-20-66813232

CIN No: L72200MH1995PLC091408 www.quickheal.co.in

Quick Heal Technologies Limited

No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness, or correctness of the information or opinions contained in this presentation. Such information and opinions are in all events not current after the date of this presentation. Certain statements made in this presentation may not be based on historical information or facts and may be "forward-looking statements" based on the currently held beliefs and assumptions of the management of Quick Heal Technologies Limited, which are expressed in good faith and in their opinion reasonable, including those relating to the Company's general business plans and strategy, its future financial condition and growth prospects and future developments in its industry and its competitive and regulatory environment.

Forward-looking statements involve known and unknown risks, uncertainties, and other factors, which may cause the actual results, financial condition, performance, or achievements of the Company or industry results to differ materially from the results, financial condition, performance, or achievements expressed or implied by such forward-looking statements, including future changes or developments in the Company's business, its competitive environment, and political, economic, legal and social conditions. Further, past performance is not necessarily indicative of future results. Given these risks, uncertainties, and other factors, viewers of this presentation are cautioned not to place undue reliance on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements to reflect future events or developments.

This presentation is for general information purposes only, without regard to any specific objectives, financial situations, or informational needs of any particular person. This presentation does not constitute an offer or invitation to purchase or subscribe for any securities in any jurisdiction, including the United States. No part of it should form the basis of or be relied upon in connection with any investment decision or any contract or commitment to purchase or subscribe for any securities. None of our securities may be offered or sold in the United States, without registration under the U.S. Securities Act of 1933, as amended, or pursuant to an exemption from registration therefrom.

This presentation is confidential and may not be copied or disseminated, in whole or in part, and any manner.

Valorem Advisors Disclaimer:

Valorem Advisors is an Independent Investor Relations Management Service company. This Presentation has been prepared by Valorem Advisors based on information and data which the Company considers reliable, but Valorem Advisors and the Company makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness, and reasonableness of the contents of this Presentation. This Presentation may not be all-inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Valorem Advisors also hereby certifies that the directors or employees of Valorem Advisors do not own any stock in personal or company capacity of the Company under review.

Thank You

Simplifying Cybersecurity

Floor 6, Building No. 1 Cerebrum IT Park, Kalyani Nagar Pune411014, INDIA Tel: +91 20 6905 3400

Independent Auditor's Review Report on Consolidated Unaudited Financial Results of Quick Heal Technologies Limited for the quarter ended June 30, 2025 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended

To the Board of Directors of Quick Heal Technologies Limited

• 1. We have reviewed the accompanying Statement of consolidated unaudited financial results of Quick Heal Technologies Limited (hereinafter referred to as 'the Holding Company'), its subsidiaries, (the Holding Company and its subsidiaries together referred to as the 'Group') for the quarter ended June 30,2025 ('the Statement') attached herewith, being submitted by the Holding Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations').
• 1. This Statement, which is the responsibility of the Holding Company's Management and approved by the Holding Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting' prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review.
• 1. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

We also performed procedures in accordance with the circular issued by the Securities and Exchange Board of India under Regulation 33 (8) of the Regulations, to the extent applicable.

1. This Statement includes the results of the Holding Company and the following entities:

Sr. No.	Name of the Entity	Relationship with the Holdin!! Company
1	Quick Heal Technologies America Inc.	Wholly owned subsidiary
2	Seorite Technologies DMCC	Wholly owned subsidiary

1. Based on our review conducted and procedures performed as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement.

[This space has been intentionally left blank]

MS KA & Associates

Chartered Accountants

1. The Statement includes the interim financial information of two subsidiaries which are not subject to review, whose interim financial information reflects total revenue of Rs. 1.20 crores, total net profit after tax of Rs. 0.02 crores and total comprehensive income of Rs. 0.02 crores for the quarter ended June 30, 2025 as considered in the Statement. These interim financial information have been furnished to us by the Management and our conclusion on the Statement in so far as it relates to the amounts and disclosures included in respect of these subsidiaries is based solely on such management prepared unaudited interim financial information. According to the information and explanations given to us by the Management, these interim financial information are not material to the Group.

Our conclusion is not modified in respect of the above matter with respect to our reliance on the financial result certified by the management.

For MS KA & Associates Chartered Accountants ICAI Firm Re~ ion No.105047W

0 4.~ ~ . e;<:J Shraddha D Khivasara Partner .,,..~o ~ Membership No.: 134285M t..lT,- 3 UDIN: .2.'S/342.95"8 1 .. cD6'80

Place: Pune Date: August 07, 2025

Floor 6, Building No. 1 • Cerebrum IT Park, Kalyani Nagar , Pune 411014, \NOIA Tel: +91 20 6905 3400

Independent Auditor's Review Report on Standalone Unaudited Financial Results of Quick Heal Technologies Limited for the quarter ended June 30, 2025 pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

To The Board of Directors of Quick Heal Technologies Limited

• 1. We have reviewed the accompanying statement of standalone unaudited financial results of Quick Heal Technologies Limited (hereinafter referred to as 'the Company') for the quarter ended June 30, 2025('the Statement') attached herewith, being submitted by the Company pursuant to the requirements of Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('the Regulations').
• 1. This Statement, which is the responsibility of the Company's Management and has been approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 'Interim Financial Reporting', prescribed under Section 133 of the Companies Act, 2013 ('the Act') read with relevant rules issued thereunder ('Ind AS 34') and other recognised accounting principles generally accepted in India and is in compliance with the Regulations. Our responsibility is to express a conclusion on the Statement based on our review.
• 1. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Institute of Chartered Accountants of India. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing specified under section 143(10) of the Act and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
• 1. Based on our review conducted as stated in paragraph 3 above, nothing has come to our attention that causes us to believe that the accompanying Statement prepared in accordance with the recognition and measurement principles laid down in Ind AS 34 and other recognised accounting principles generally accepted in India has not disclosed the information required to be disclosed in terms of the Regulations, including the manner in which it is to be disclosed, or that it contains any material misstatement.

Place: Pune Date: August 07, 2025